CommunityNews & Policy

Oral Wegovy approved by FDA

31 replies19 peopleDec 22, 2025☆ Follow
Summary

How does the new oral Wegovy compare to injections and other oral GLP-1 options for weight loss?

The thread discusses the newly approved oral semaglutide pill, noting it achieves around 14% weight loss but requires strict empty-stomach dosing like existing orals. Participants see it as more accessible for injection-averse users and potentially useful for maintenance, though injections remain stronger overall. Some mention emerging oral candidates in development that may outperform current options.

What this discussion establishesWhere people disagree

Whether daily orals will be widely adopted versus weekly injections, with some users strongly preferring shots for convenience and potency while others value avoiding needles.

Still open

How well the oral version performs if dosing instructions are not followed exactly, and which upcoming oral candidates will ultimately prove best.

Nothing here is advice.

31 replies · 19 people
IronWillow10archiveopening postDec 22, 2025

Interesting.

ClearHarbour45archiveDec 22, 2025
↳ replying to @IronWillow10 (opening post)

Haven't looked at it yet. Did absorption look decent? We're probably all hooked on the shots anyway lol...

SharpFenwick93archiveDec 22, 2025

Having more choices available sounds good to me. It's nice seeing weight loss meds reach folks who get nervous about shots. Sure some versions work a lot stronger but we're really just getting started.

PatientQuill64archiveDec 23, 2025

It would be interesting to have direct matchup tests between this option and the other compound. Taking twenty five milligrams daily seems to require a greater quantity of the glp one agonist for matching outcomes. The intake schedule matches the tablet version exactly, so this comes across as simply a larger amount of the established product rather than a fresh development.

SharpFenwick93archiveDec 23, 2025
↳ replying to @PatientQuill64

I hear this one edges out the alternative by a small margin but gets there in less time overall, so my guess is that coverage rules will decide things for most folks or else it just comes down to which company rep visits the physicians ahead of the others.

IronWillow10archiveDec 23, 2025

These haven't gone up against each other in one trial. Separate research shows one pill version gave fourteen percent body weight drop in sixty four weeks while placebo only two percent. The other pill hit eleven percent in seventy two weeks on max dose with placebo at two percent. One shot got fifteen percent in its primary study against two percent placebo and the last one twenty one percent at top dose compared to three percent placebo.

CopperLedger37archiveDec 23, 2025
↳ replying to @SharpFenwick93

I agree it's not the top option around, yet a decade earlier this could have looked like a wonder cure. Still, the cheaper price tag plus skipping needles means plenty of folks will try this instead of those other treatments.

PatientQuill64archiveDec 23, 2025
↳ replying to @IronWillow10

I picked up some of this oral version and plan to give it a try early in the year ahead. These tablet forms look like they could work well to hold steady after reaching targets through shots. They might suit folks with milder extra weight too but the injectable route especially the stronger ones should stay on top.

CopperFenwick68archiveDec 23, 2025
↳ replying to @IronWillow10 (opening post)

Dealing with nothing in my belly beforehand always slips my mind and feels really tough.

IronWillow10archiveDec 23, 2025
↳ replying to @CopperFenwick68

I wonder what the consequences are when you skip that part.

CopperWillow54archiveDec 23, 2025

This isn’t new. The existing oral sema has been out since 2019.

CopperMarble12archiveDec 23, 2025
↳ replying to @IronWillow10

I've joined drug trials in the past though none focused on dropping pounds. Believe me the folks taking part are ordinary people just like anyone else and they sometimes fail to follow every instruction exactly. That probably explains why the study outcomes end up weaker than hoped. The records we already have show what occurs if certain participants skip the empty stomach rule.

WarmMeadow92archiveDec 23, 2025
↳ replying to @IronWillow10 (opening post)

I feel the same way. After hitting the upkeep stage those tablet versions could serve as practical straightforward choices. I'd probably handle covering that recurring monthly cost for good since it comes across as reasonable and doable on my end unlike the steeper outlay tied to the direct service. The one snag is this reduced rate serving as an intro deal plus uncertainty over whether the initial level would prove adequate.

KeenTimber66archiveDec 23, 2025
↳ replying to @ClearHarbour45

Yeah that's definitely me. Really looking forward to getting the syringe ready. haha

WarmQuill37archiveDec 23, 2025

Getting an injection weekly appeals to me more than needing to recall taking medication each day.

BrightMeadow15archiveDec 23, 2025
↳ replying to @PatientQuill64

I noticed something in the report about needing an extra element to shield from digestive juices. The same trick could apply here for the swallowed form, though it might not. That concept strikes me as noteworthy overall. Perhaps users will try adding some baking soda with their peptide to let it last until uptake occurs. It comes across as rather basic.

AmberMarble84archiveDec 23, 2025

I don't think much of it. A few folks I treat take that diabetes version, and they mainly deal with stomach discomfort. Appetite stays the same, though blood sugar control sees some improvement. I'd go with the other choice every time instead of this tablet.

SharpFenwick93archiveDec 23, 2025

In an investment discussion board someone mentioned a triple agonist compound during its first human trial at a large pharma firm might come as a tablet form. That's just unconfirmed talk though. Among other tablet versions out there one dual target option posted strong mid stage data that topped existing choices by a wide margin with notable body mass drop after roughly three months instead of the much longer span needed for another candidate. Later stage testing has started signing people up from what I gather. A separate outfit is running daily dosing trials on a single receptor agonist at the second stage. Still another firm has a combined molecule in tablet form also at that same stage. Added extra notes about the dual target option. Now pretty excited about that dual target option. Wonder if anyone is already producing it?

SlowBramble61archiveDec 23, 2025

Took the tablet form for eight weeks but saw zero effect at all. My weight went up instead.

SharpFenwick93archiveDec 23, 2025
↳ replying to @SlowBramble61

Wow. Was it the Viking one or something different?

SlowBramble61archiveDec 23, 2025
↳ replying to @SharpFenwick93

It was from a compounder. I assume it was trash.

SharpFenwick93archiveDec 23, 2025

Maybe the mix lacked whatever extras would shield it from breaking down in stomach acid. That would explain the outcome. The outfit got results close to what shots achieve based on some prior trial stage so they worked out a way past the digestive barrier or maybe the group whose formula they acquired had already done that.

PlainKettle50archiveDec 23, 2025

I'm puzzled why folks might pick the tablet form when shots have gone out of date.

SteadyTimber49archiveDec 23, 2025
↳ replying to @WarmQuill37

Yeah, my five offspring make it clear I'm no good at sticking with daily medication.

WarmQuill37archiveDec 23, 2025
↳ replying to @PlainKettle50

A bunch of individuals aren't keen on needles.

PlainKettle50archiveDec 23, 2025
↳ replying to @WarmQuill37

I switched to a 31 gauge needle for shots and noticed zero sensation whatsoever. Now that I've felt how injections put far less strain on my system than swallowing the same stuff, plus deliver stronger outcomes, going back to the oral route seems pointless. The difference stands out clearly.

PatientQuill64archiveDec 23, 2025
↳ replying to @PlainKettle50

Some folks mention disliking shots, and I agree that could limit appeal for certain users. This approach might suit upkeep after reaching a goal, or appeal to those aiming for modest reductions around eight to fifteen percent. It would never fit my situation beyond upkeep since my target sits near forty percent total from the start, though I have already reached twenty four percent so far. Still, I expect oral versions of these compounds to gain solid traction commercially. Places like this forum along with similar online spots do not reflect typical reasons or choices people make. Many here seem hooked on shots and always hunting for maximum drops, whereas everyday folks beyond those circles could accept pills provided the drawbacks stay manageable and costs feel reasonable.

WarmQuill37archiveDec 23, 2025
↳ replying to @PlainKettle50

Needles have never bothered me personally. Yet plenty of folks feel differently about them and refuse to give that approach any consideration.

BrightMeadow15archiveDec 24, 2025
↳ replying to @PatientQuill64

I've come across that idea so often by now. Countless folks out there appear eager to hand over cash for something that effortless if only it existed.

RustFenwick38archiveDec 30, 2025

Curious whether this pill version might appear in the unregulated market before long. It seems another compound in that category can already be obtained that way, suggesting producers are capable of creating tablet forms. That could simplify getting started for those hesitant around injections or uncertain about preparing the solution themselves, though it has upsides and downsides since simpler entry could lead to broader use.

Add your experience

If you have tried it, this topic is still open. Sign in to reply — it takes a minute.

Oral Wegovy approved by FDA · ZyraTrack Community